Healthcare provider profile · identity verified

Diane E Reed, FNP

Nurse Practitioner · WOODHULL, NY · NPI 1316032410

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	476	125
Levothyroxine Sodium	Levothyroxine Sodium	360	71
Amlodipine Besylate	Amlodipine Besylate	352	78
Lisinopril	Lisinopril	265	70
Metoprolol Succinate	Metoprolol Succinate	214	48
Pantoprazole Sodium	Pantoprazole Sodium	204	45
Omeprazole	Omeprazole	200	55
Gabapentin	Gabapentin	180	46
Albuterol Sulfate Hfa	Albuterol Sulfate	178	56
Azithromycin	Azithromycin	176	116
Tamsulosin Hcl	Tamsulosin Hcl	148	52
Trulicity	Dulaglutide	148	18
Metformin Hcl	Metformin Hcl	130	34
Metoprolol Tartrate	Metoprolol Tartrate	118	29
Citalopram Hbr	Citalopram Hydrobromide	114	27
Torsemide	Torsemide	114	35
Hydrochlorothiazide	Hydrochlorothiazide	113	31
Losartan Potassium	Losartan Potassium	111	32
Potassium Chloride	Potassium Chloride	111	33
Prednisone	Prednisone	92	39
Sertraline Hcl	Sertraline Hcl	92	17
Fluticasone Propionate	Fluticasone Propionate	86	33
Metformin Hcl Er	Metformin Hcl	86	25
Gemfibrozil	Gemfibrozil	78	22
Eliquis	Apixaban	76	20
Doxycycline Hyclate	Doxycycline Hyclate	74	46
Candesartan Cilexetil	Candesartan Cilexetil	73	13
Alprazolam	Alprazolam	72	12
Meloxicam	Meloxicam	72	23
Pravastatin Sodium	Pravastatin Sodium	72	21
Clopidogrel	Clopidogrel Bisulfate	67	24
Isosorbide Mononitrate Er	Isosorbide Mononitrate	66	14
Fluconazole	Fluconazole	64	37
Rosuvastatin Calcium	Rosuvastatin Calcium	62	17
Cefuroxime	Cefuroxime Axetil	61	41
Cephalexin	Cephalexin	61	49
Escitalopram Oxalate	Escitalopram Oxalate	59	14
Zolpidem Tartrate	Zolpidem Tartrate	58	suppressed
Montelukast Sodium	Montelukast Sodium	57	16
Allopurinol	Allopurinol	54	suppressed
Finasteride	Finasteride	53	12
Famotidine	Famotidine	52	15
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	52	18
Celecoxib	Celecoxib	51	12
Nystatin	Nystatin	51	19
Atenolol	Atenolol	50	12
Glimepiride	Glimepiride	50	14
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	48	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	47	34
Fenofibrate	Fenofibrate Nanocrystallized	46	14
Duloxetine Hcl	Duloxetine Hcl	44	suppressed
Ropinirole Hcl	Ropinirole Hcl	43	suppressed
Warfarin Sodium	Warfarin Sodium	42	suppressed
Mounjaro	Tirzepatide	41	suppressed
Synthroid	Levothyroxine Sodium	41	suppressed
Bupropion Hcl Sr	Bupropion Hcl	40	suppressed
Ibuprofen	Ibuprofen	40	18
Lorazepam	Lorazepam	40	suppressed
Alendronate Sodium	Alendronate Sodium	39	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	39	28
Pregabalin	Pregabalin	39	suppressed
Trazodone Hcl	Trazodone Hcl	39	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	38	suppressed
Lansoprazole	Lansoprazole	38	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	38	12
Amoxicillin	Amoxicillin	36	26
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	36	13
Simvastatin	Simvastatin	36	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	34	13
Acyclovir	Acyclovir	33	12
Breo Ellipta	Fluticasone/Vilanterol	33	suppressed
Symbicort	Budesonide/Formoterol Fumarate	33	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	32	suppressed
Furosemide	Furosemide	31	suppressed
Meclizine Hcl	Meclizine Hcl	31	11
Ezetimibe	Ezetimibe	30	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	28	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	28	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	27	16
Glipizide	Glipizide	27	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	27	suppressed
Clonazepam	Clonazepam	26	suppressed
Fenofibrate	Fenofibrate	26	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	26	suppressed
Carvedilol	Carvedilol	24	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	24	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	24	suppressed
Buspirone Hcl	Buspirone Hcl	23	suppressed
Colchicine	Colchicine	23	suppressed
Topiramate	Topiramate	23	suppressed
Ozempic	Semaglutide	22	suppressed
Spironolactone	Spironolactone	22	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	13
Quetiapine Fumarate	Quetiapine Fumarate	21	suppressed
Levetiracetam	Levetiracetam	20	suppressed
Mupirocin	Mupirocin	20	16
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	20	suppressed
Ramipril	Ramipril	20	suppressed
Valsartan	Valsartan	20	suppressed
Estradiol	Estradiol	19	suppressed
Naproxen	Naproxen	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	18	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	18	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	17	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	17	suppressed
Gentamicin Sulfate	Gentamicin Sulfate	16	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	16	suppressed
Risperidone	Risperidone	16	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	15	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Tamoxifen Citrate	Tamoxifen Citrate	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	14	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Estradiol (Twice Weekly)	Estradiol	14	suppressed
Jardiance	Empagliflozin	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Vraylar	Cariprazine Hcl	14	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Divalproex Sodium	Divalproex Sodium	13	suppressed
Lidocaine	Lidocaine	13	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Mirtazapine	Mirtazapine	13	suppressed
Ranolazine Er	Ranolazine	13	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Tizanidine Hcl	Tizanidine Hcl	12	suppressed
Vascepa	Icosapent Ethyl	12	suppressed
Breyna	Budesonide/Formoterol Fumarate	11	suppressed
Dulera	Mometasone/Formoterol	11	suppressed
Levofloxacin	Levofloxacin	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Premarin	Estrogens, Conjugated	11	suppressed
Tri-Sprintec	Norgestimate-Ethinyl Estradiol	11	suppressed
Trospium Chloride Er	Trospium Chloride	11	suppressed
Varenicline Tartrate	Varenicline Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error